 Nichole Reisdorph
Concepts (615)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 24 | 2023 | 538 | 4.820 |
Why?
| | Metabolome | 12 | 2023 | 287 | 2.310 |
Why?
| | Mass Spectrometry | 22 | 2021 | 645 | 2.270 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 414 | 2.090 |
Why?
| | Proteomics | 12 | 2019 | 859 | 1.480 |
Why?
| | Bronchoalveolar Lavage Fluid | 8 | 2018 | 608 | 1.460 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.450 |
Why?
| | Proteome | 8 | 2019 | 345 | 1.370 |
Why?
| | Lipids | 6 | 2022 | 588 | 1.280 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2020 | 477 | 1.240 |
Why?
| | Asthma | 11 | 2022 | 2066 | 1.190 |
Why?
| | Biomarkers | 24 | 2023 | 3467 | 0.960 |
Why?
| | Research | 2 | 2018 | 396 | 0.950 |
Why?
| | Amino Acids | 4 | 2020 | 454 | 0.920 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 20 | 0.890 |
Why?
| | Chromatography, Liquid | 10 | 2023 | 347 | 0.880 |
Why?
| | Eicosanoids | 4 | 2022 | 55 | 0.820 |
Why?
| | Lung | 10 | 2022 | 3673 | 0.810 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 90 | 0.800 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 168 | 0.790 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.760 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.760 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 24 | 0.740 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 1098 | 0.740 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 15 | 0.710 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 10 | 0.690 |
Why?
| | Ozone | 4 | 2022 | 99 | 0.690 |
Why?
| | Breath Tests | 2 | 2017 | 83 | 0.670 |
Why?
| | Animals | 53 | 2023 | 32102 | 0.670 |
Why?
| | Food | 2 | 2020 | 160 | 0.660 |
Why?
| | Mice | 37 | 2023 | 15052 | 0.640 |
Why?
| | Organic Chemicals | 1 | 2020 | 116 | 0.630 |
Why?
| | Phosphopeptides | 1 | 2018 | 15 | 0.630 |
Why?
| | Peptide Mapping | 1 | 2018 | 59 | 0.630 |
Why?
| | Databases, Chemical | 1 | 2018 | 7 | 0.620 |
Why?
| | Monocytes | 1 | 2021 | 507 | 0.610 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 1724 | 0.600 |
Why?
| | Isotope Labeling | 1 | 2018 | 76 | 0.590 |
Why?
| | Tyrosine | 1 | 2018 | 219 | 0.590 |
Why?
| | Skin | 3 | 2018 | 662 | 0.580 |
Why?
| | Macrophages | 2 | 2021 | 1284 | 0.560 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 221 | 0.550 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 374 | 0.550 |
Why?
| | Hypersensitivity | 4 | 2022 | 260 | 0.550 |
Why?
| | Smoking | 7 | 2020 | 1457 | 0.550 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 316 | 0.540 |
Why?
| | Plasma | 2 | 2017 | 213 | 0.540 |
Why?
| | Humans | 69 | 2023 | 115611 | 0.530 |
Why?
| | Saliva | 1 | 2017 | 189 | 0.520 |
Why?
| | Computational Biology | 3 | 2020 | 537 | 0.510 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 125 | 0.510 |
Why?
| | Glycerophospholipids | 4 | 2022 | 29 | 0.500 |
Why?
| | Mitochondria | 5 | 2023 | 750 | 0.490 |
Why?
| | Peptides | 4 | 2019 | 864 | 0.490 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 535 | 0.480 |
Why?
| | Cell Differentiation | 2 | 2021 | 1700 | 0.470 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 100 | 0.460 |
Why?
| | Leukotriene E4 | 3 | 2013 | 27 | 0.460 |
Why?
| | Microbiota | 4 | 2022 | 653 | 0.430 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 165 | 0.430 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 26 | 0.430 |
Why?
| | Software | 4 | 2020 | 541 | 0.430 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 89 | 0.410 |
Why?
| | Endocannabinoids | 2 | 2022 | 37 | 0.410 |
Why?
| | Sirtuin 3 | 3 | 2023 | 52 | 0.400 |
Why?
| | Liver | 4 | 2020 | 1690 | 0.390 |
Why?
| | Autoantigens | 4 | 2019 | 398 | 0.390 |
Why?
| | Reproducibility of Results | 7 | 2020 | 2800 | 0.380 |
Why?
| | Eicosapentaenoic Acid | 2 | 2021 | 28 | 0.370 |
Why?
| | Transcriptome | 4 | 2022 | 736 | 0.360 |
Why?
| | Cholesterol | 2 | 2023 | 369 | 0.360 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 124 | 0.360 |
Why?
| | Male | 40 | 2023 | 55967 | 0.350 |
Why?
| | Sleep Deprivation | 2 | 2023 | 166 | 0.350 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 193 | 0.330 |
Why?
| | Analgesia | 1 | 2010 | 82 | 0.320 |
Why?
| | Species Specificity | 2 | 2020 | 552 | 0.320 |
Why?
| | Mice, Inbred C57BL | 9 | 2022 | 4773 | 0.320 |
Why?
| | Workflow | 2 | 2020 | 136 | 0.300 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 1718 | 0.300 |
Why?
| | Middle Aged | 19 | 2023 | 27014 | 0.300 |
Why?
| | Female | 36 | 2023 | 59931 | 0.300 |
Why?
| | Kainic Acid | 2 | 2018 | 31 | 0.290 |
Why?
| | Urinalysis | 2 | 2020 | 62 | 0.290 |
Why?
| | Blood Pressure | 4 | 2020 | 1537 | 0.280 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 219 | 0.280 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 48 | 0.280 |
Why?
| | Inflammation Mediators | 2 | 2020 | 479 | 0.280 |
Why?
| | Obesity | 6 | 2022 | 2517 | 0.270 |
Why?
| | Diet | 3 | 2023 | 1072 | 0.270 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 324 | 0.260 |
Why?
| | Disease Models, Animal | 8 | 2021 | 3580 | 0.260 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 466 | 0.260 |
Why?
| | Diet, High-Fat | 3 | 2022 | 225 | 0.260 |
Why?
| | Body Fluids | 2 | 2017 | 58 | 0.260 |
Why?
| | Sleep | 4 | 2023 | 625 | 0.260 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 310 | 0.260 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 192 | 0.250 |
Why?
| | Sodium Nitrite | 2 | 2015 | 37 | 0.250 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 88 | 0.250 |
Why?
| | Pilot Projects | 6 | 2022 | 1377 | 0.250 |
Why?
| | Ethanol | 2 | 2019 | 549 | 0.240 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 965 | 0.240 |
Why?
| | Docosahexaenoic Acids | 3 | 2021 | 69 | 0.240 |
Why?
| | Flavoproteins | 1 | 2004 | 7 | 0.240 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 3 | 0.240 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 5 | 0.240 |
Why?
| | Pneumonia | 2 | 2021 | 576 | 0.230 |
Why?
| | Dietary Supplements | 4 | 2022 | 458 | 0.230 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 85 | 0.230 |
Why?
| | Agaricus | 1 | 2023 | 2 | 0.230 |
Why?
| | Salmon | 1 | 2023 | 12 | 0.230 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 20 | 0.230 |
Why?
| | Eye Proteins | 1 | 2004 | 73 | 0.230 |
Why?
| | Seafood | 1 | 2023 | 16 | 0.230 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 47 | 0.230 |
Why?
| | Proteins | 3 | 2017 | 920 | 0.230 |
Why?
| | Oxadiazoles | 1 | 2003 | 32 | 0.220 |
Why?
| | Rhinovirus | 1 | 2003 | 41 | 0.220 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 139 | 0.220 |
Why?
| | Isoxazoles | 1 | 2003 | 56 | 0.220 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 69 | 0.220 |
Why?
| | Capsid | 1 | 2003 | 76 | 0.220 |
Why?
| | Hippocampus | 2 | 2018 | 709 | 0.210 |
Why?
| | Arachidonic Acids | 1 | 2022 | 58 | 0.210 |
Why?
| | Oxidative Stress | 4 | 2021 | 1093 | 0.210 |
Why?
| | Drosophila Proteins | 1 | 2004 | 159 | 0.210 |
Why?
| | Acylation | 2 | 2019 | 28 | 0.210 |
Why?
| | Prostaglandins | 2 | 2022 | 78 | 0.210 |
Why?
| | Cell Line | 6 | 2019 | 2651 | 0.200 |
Why?
| | Cells, Cultured | 6 | 2021 | 3914 | 0.200 |
Why?
| | Myocardium | 3 | 2019 | 926 | 0.200 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.200 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 318 | 0.200 |
Why?
| | Linear Models | 2 | 2018 | 776 | 0.200 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 31 | 0.200 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 46 | 0.200 |
Why?
| | Mice, Knockout | 9 | 2021 | 2604 | 0.200 |
Why?
| | Sepsis | 1 | 2007 | 515 | 0.200 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 85 | 0.190 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 313 | 0.190 |
Why?
| | Bacterial Toxins | 1 | 2022 | 103 | 0.190 |
Why?
| | Dinoprostone | 1 | 2022 | 186 | 0.190 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 139 | 0.190 |
Why?
| | Brain Chemistry | 1 | 2021 | 116 | 0.190 |
Why?
| | Calcifediol | 2 | 2022 | 29 | 0.190 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 20 | 0.190 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 16 | 0.190 |
Why?
| | Lipid Metabolism | 3 | 2018 | 449 | 0.190 |
Why?
| | Amidohydrolases | 1 | 2021 | 29 | 0.190 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 39 | 0.190 |
Why?
| | Neuroprotection | 1 | 2021 | 30 | 0.190 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 24 | 0.180 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 159 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 501 | 0.180 |
Why?
| | Melatonin | 1 | 2021 | 106 | 0.180 |
Why?
| | Aged | 11 | 2023 | 19255 | 0.180 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 46 | 0.180 |
Why?
| | Cross-Over Studies | 2 | 2020 | 434 | 0.180 |
Why?
| | Insulin | 3 | 2022 | 2082 | 0.180 |
Why?
| | Nasal Polyps | 1 | 2020 | 49 | 0.180 |
Why?
| | Bariatric Surgery | 1 | 2022 | 162 | 0.180 |
Why?
| | Phosphorylation | 4 | 2019 | 1571 | 0.180 |
Why?
| | Vital Capacity | 2 | 2018 | 277 | 0.180 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 90 | 0.180 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 105 | 0.180 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 134 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 83 | 0.170 |
Why?
| | Lung Injury | 1 | 2022 | 199 | 0.170 |
Why?
| | Biotransformation | 1 | 2020 | 50 | 0.170 |
Why?
| | Tubulin | 1 | 2020 | 123 | 0.170 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 7 | 0.170 |
Why?
| | Umbilical Arteries | 1 | 2020 | 41 | 0.170 |
Why?
| | Aging | 3 | 2023 | 1631 | 0.170 |
Why?
| | Succinic Acid | 1 | 2019 | 43 | 0.170 |
Why?
| | Vitamins | 1 | 2021 | 151 | 0.170 |
Why?
| | Liposomes | 1 | 2020 | 149 | 0.170 |
Why?
| | Myofibrils | 1 | 2019 | 46 | 0.170 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 92 | 0.170 |
Why?
| | Islets of Langerhans | 2 | 2019 | 729 | 0.170 |
Why?
| | Uterine Artery | 1 | 2020 | 67 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2020 | 103 | 0.170 |
Why?
| | Epithelium | 1 | 2020 | 297 | 0.170 |
Why?
| | Anthracenes | 1 | 2019 | 28 | 0.170 |
Why?
| | Synapses | 1 | 2022 | 336 | 0.160 |
Why?
| | Rhinitis | 1 | 2020 | 128 | 0.160 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 15 | 0.160 |
Why?
| | Inhalation Exposure | 2 | 2021 | 102 | 0.160 |
Why?
| | Fluorenes | 1 | 2019 | 38 | 0.160 |
Why?
| | Adult | 14 | 2023 | 30726 | 0.160 |
Why?
| | Dietary Proteins | 1 | 2020 | 123 | 0.160 |
Why?
| | Spleen | 1 | 2020 | 492 | 0.160 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 187 | 0.160 |
Why?
| | C-Peptide | 2 | 2016 | 138 | 0.160 |
Why?
| | Sinusitis | 1 | 2020 | 175 | 0.160 |
Why?
| | Trypsin | 1 | 2018 | 67 | 0.160 |
Why?
| | Microtubules | 1 | 2020 | 238 | 0.160 |
Why?
| | Cysteine | 1 | 2019 | 173 | 0.160 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 37 | 0.160 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 68 | 0.150 |
Why?
| | Leukotrienes | 1 | 2018 | 35 | 0.150 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 21 | 0.150 |
Why?
| | Gene Expression | 4 | 2020 | 1436 | 0.150 |
Why?
| | Limit of Detection | 1 | 2018 | 55 | 0.150 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 237 | 0.150 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 33 | 0.150 |
Why?
| | Niacinamide | 1 | 2018 | 65 | 0.150 |
Why?
| | NAD | 1 | 2018 | 67 | 0.150 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 5 | 0.150 |
Why?
| | Kynurenine | 1 | 2018 | 80 | 0.150 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 3 | 0.150 |
Why?
| | Adiponectin | 2 | 2022 | 214 | 0.150 |
Why?
| | Inflammasomes | 1 | 2018 | 116 | 0.150 |
Why?
| | Interleukin-6 | 2 | 2021 | 677 | 0.150 |
Why?
| | Sample Size | 1 | 2017 | 115 | 0.140 |
Why?
| | Influenza, Human | 1 | 2022 | 548 | 0.140 |
Why?
| | Immunophenotyping | 2 | 2018 | 277 | 0.140 |
Why?
| | Health | 1 | 2017 | 74 | 0.140 |
Why?
| | Hydrolases | 1 | 2017 | 51 | 0.140 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 73 | 0.140 |
Why?
| | Hyperglycemia | 1 | 2020 | 295 | 0.140 |
Why?
| | Sex Characteristics | 1 | 2021 | 641 | 0.140 |
Why?
| | Orthomyxoviridae Infections | 1 | 2017 | 55 | 0.140 |
Why?
| | Autoimmunity | 2 | 2021 | 822 | 0.140 |
Why?
| | Proline | 1 | 2017 | 72 | 0.140 |
Why?
| | Sphingolipids | 1 | 2017 | 59 | 0.140 |
Why?
| | Antibodies | 1 | 2018 | 374 | 0.140 |
Why?
| | Disease | 1 | 2017 | 87 | 0.140 |
Why?
| | Actins | 1 | 2018 | 383 | 0.140 |
Why?
| | Artifacts | 1 | 2017 | 122 | 0.140 |
Why?
| | Immunity, Humoral | 1 | 2017 | 112 | 0.130 |
Why?
| | Cardiomyopathies | 1 | 2019 | 303 | 0.130 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 124 | 0.130 |
Why?
| | Signal Transduction | 4 | 2022 | 4541 | 0.130 |
Why?
| | HEK293 Cells | 1 | 2018 | 602 | 0.130 |
Why?
| | Epitopes | 2 | 2016 | 438 | 0.130 |
Why?
| | Acetylation | 3 | 2023 | 212 | 0.130 |
Why?
| | Vascular Stiffness | 2 | 2018 | 411 | 0.130 |
Why?
| | Arginine | 1 | 2017 | 241 | 0.130 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 101 | 0.130 |
Why?
| | Brain | 2 | 2018 | 2373 | 0.130 |
Why?
| | Emphysema | 2 | 2013 | 124 | 0.130 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 170 | 0.130 |
Why?
| | Apoptosis | 4 | 2017 | 2377 | 0.130 |
Why?
| | Aorta | 2 | 2015 | 353 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 324 | 0.130 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2000 | 0.130 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 235 | 0.120 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 36 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 10 | 0.120 |
Why?
| | Electrophysiology | 1 | 2015 | 202 | 0.120 |
Why?
| | Forensic Sciences | 1 | 2014 | 6 | 0.120 |
Why?
| | Chlorine | 1 | 2015 | 62 | 0.120 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 161 | 0.120 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 245 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2022 | 1078 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2015 | 183 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3255 | 0.120 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 88 | 0.110 |
Why?
| | Interleukin-16 | 1 | 2013 | 7 | 0.110 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 41 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 19 | 0.110 |
Why?
| | Lung Diseases | 2 | 2013 | 710 | 0.110 |
Why?
| | Methyl Ethers | 1 | 2013 | 7 | 0.110 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 14 | 0.110 |
Why?
| | Health Status | 1 | 2018 | 728 | 0.110 |
Why?
| | Alcohol Drinking | 1 | 2019 | 650 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2018 | 3023 | 0.110 |
Why?
| | Up-Regulation | 2 | 2019 | 820 | 0.110 |
Why?
| | Methanol | 1 | 2013 | 30 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2017 | 377 | 0.110 |
Why?
| | Education | 1 | 2013 | 99 | 0.110 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 129 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1002 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1447 | 0.100 |
Why?
| | Epilepsy | 1 | 2016 | 290 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 177 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2017 | 773 | 0.100 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 924 | 0.100 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 560 | 0.100 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 40 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2018 | 6419 | 0.100 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 238 | 0.100 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 249 | 0.100 |
Why?
| | Heart Diseases | 1 | 2015 | 330 | 0.100 |
Why?
| | Calcium | 1 | 2017 | 1103 | 0.100 |
Why?
| | Fatty Acids | 3 | 2018 | 386 | 0.100 |
Why?
| | Ovarian Follicle | 1 | 2011 | 61 | 0.090 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2790 | 0.090 |
Why?
| | fas Receptor | 1 | 2011 | 93 | 0.090 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 24 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 633 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 312 | 0.090 |
Why?
| | Rats | 4 | 2022 | 5034 | 0.090 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 32 | 0.090 |
Why?
| | Aluminum | 1 | 2010 | 34 | 0.090 |
Why?
| | Mice, Obese | 2 | 2021 | 52 | 0.090 |
Why?
| | Dietary Fats | 2 | 2022 | 289 | 0.090 |
Why?
| | Light | 2 | 2021 | 337 | 0.090 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 112 | 0.090 |
Why?
| | Sarcomeres | 1 | 2010 | 89 | 0.090 |
Why?
| | Ovary | 1 | 2011 | 190 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2353 | 0.090 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 15 | 0.090 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 30 | 0.090 |
Why?
| | Chromogranin A | 1 | 2010 | 39 | 0.090 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 350 | 0.090 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1057 | 0.080 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 845 | 0.080 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 63 | 0.080 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 206 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2098 | 0.080 |
Why?
| | Protein C | 1 | 2009 | 44 | 0.080 |
Why?
| | Binding Sites | 2 | 2020 | 1177 | 0.080 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2022 | 489 | 0.080 |
Why?
| | Glycoproteins | 1 | 2010 | 309 | 0.080 |
Why?
| | Cognition | 1 | 2015 | 981 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2010 | 304 | 0.080 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 549 | 0.080 |
Why?
| | Sirtuins | 2 | 2019 | 32 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2010 | 209 | 0.080 |
Why?
| | Respiratory Mucosa | 1 | 2010 | 258 | 0.080 |
Why?
| | Sphingomyelins | 2 | 2020 | 28 | 0.080 |
Why?
| | Exercise | 1 | 2018 | 1609 | 0.080 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 45 | 0.080 |
Why?
| | Vasoconstriction | 1 | 2009 | 185 | 0.080 |
Why?
| | Glucose | 2 | 2023 | 904 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 693 | 0.080 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 330 | 0.080 |
Why?
| | Biomedical Research | 1 | 2013 | 588 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2262 | 0.070 |
Why?
| | Diet, Western | 2 | 2018 | 66 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 370 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 340 | 0.070 |
Why?
| | Curriculum | 1 | 2013 | 853 | 0.070 |
Why?
| | Phenotype | 4 | 2018 | 2831 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 1918 | 0.070 |
Why?
| | Pregnancy | 4 | 2021 | 5550 | 0.070 |
Why?
| | Disease Susceptibility | 2 | 2019 | 316 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 1964 | 0.070 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 337 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 353 | 0.070 |
Why?
| | Interleukin-13 | 2 | 2020 | 126 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 839 | 0.070 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 376 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2010 | 675 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 826 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1168 | 0.060 |
Why?
| | Child | 5 | 2022 | 18486 | 0.060 |
Why?
| | Young Adult | 5 | 2020 | 10487 | 0.060 |
Why?
| | Algal Proteins | 1 | 2004 | 4 | 0.060 |
Why?
| | Protein Binding | 2 | 2020 | 1917 | 0.060 |
Why?
| | Cryptochromes | 1 | 2004 | 23 | 0.060 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 64 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 61 | 0.060 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 49 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 263 | 0.060 |
Why?
| | Oxazoles | 1 | 2003 | 29 | 0.060 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 136 | 0.060 |
Why?
| | Quality Control | 1 | 2023 | 147 | 0.060 |
Why?
| | Protoplasts | 1 | 2003 | 7 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 544 | 0.060 |
Why?
| | Down-Regulation | 2 | 2020 | 601 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 2751 | 0.050 |
Why?
| | Introns | 1 | 2004 | 226 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 3364 | 0.050 |
Why?
| | Exons | 1 | 2004 | 300 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 185 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 67 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 6 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 8 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 409 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 14 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 339 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1243 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 75 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 29 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 42 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 793 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 28 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2018 | 1659 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 47 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 28 | 0.050 |
Why?
| | Oxylipins | 1 | 2022 | 27 | 0.050 |
Why?
| | Adolescent | 4 | 2020 | 17903 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2008 | 1024 | 0.050 |
Why?
| | Inflammation | 2 | 2022 | 2499 | 0.050 |
Why?
| | HeLa Cells | 1 | 2003 | 567 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 107 | 0.050 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 135 | 0.050 |
Why?
| | Neurons | 2 | 2023 | 1298 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 124 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2022 | 94 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2420 | 0.050 |
Why?
| | Leptin | 1 | 2022 | 211 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 16 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1737 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 156 | 0.050 |
Why?
| | Sirtuin 2 | 1 | 2020 | 13 | 0.050 |
Why?
| | Glutamic Acid | 1 | 2022 | 213 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 31 | 0.050 |
Why?
| | Minerals | 1 | 2021 | 37 | 0.050 |
Why?
| | Adenosine | 1 | 2022 | 203 | 0.050 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 53 | 0.050 |
Why?
| | Prescriptions | 1 | 2021 | 60 | 0.050 |
Why?
| | Cohort Studies | 2 | 2021 | 4945 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 66 | 0.050 |
Why?
| | Metaplasia | 1 | 2020 | 54 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 102 | 0.050 |
Why?
| | Placental Insufficiency | 1 | 2021 | 102 | 0.050 |
Why?
| | Phosphatidylserines | 1 | 2020 | 87 | 0.050 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 43 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 232 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 169 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 473 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 211 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 33 | 0.040 |
Why?
| | Mucus | 1 | 2020 | 55 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 241 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 527 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 135 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 48 | 0.040 |
Why?
| | Water | 1 | 2003 | 412 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 77 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 92 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2127 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 101 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 163 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 38 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 523 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 84 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 290 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 105 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 341 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 476 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 75 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 152 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 408 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 375 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 764 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 206 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 203 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 160 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 162 | 0.040 |
Why?
| | Metagenomics | 1 | 2020 | 131 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 209 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 42 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 329 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 137 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 780 | 0.040 |
Why?
| | Germinal Center | 1 | 2018 | 49 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 133 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 66 | 0.040 |
Why?
| | Models, Molecular | 1 | 2003 | 1390 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 164 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 235 | 0.040 |
Why?
| | Pyridinium Compounds | 1 | 2018 | 13 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 1805 | 0.040 |
Why?
| | Weight Loss | 1 | 2022 | 633 | 0.040 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 1 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 141 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2021 | 371 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2018 | 17 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 398 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1087 | 0.040 |
Why?
| | Methionine | 1 | 2018 | 145 | 0.040 |
Why?
| | Lysine | 1 | 2019 | 245 | 0.040 |
Why?
| | Energy Intake | 1 | 2020 | 414 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 268 | 0.040 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 337 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2017 | 2574 | 0.040 |
Why?
| | Nutritional Status | 1 | 2020 | 289 | 0.040 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 145 | 0.040 |
Why?
| | Pyridines | 1 | 2021 | 425 | 0.040 |
Why?
| | Immunoprecipitation | 1 | 2018 | 154 | 0.040 |
Why?
| | Fetus | 1 | 2021 | 702 | 0.040 |
Why?
| | Feces | 1 | 2019 | 372 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1440 | 0.040 |
Why?
| | Tissue Donors | 1 | 2019 | 331 | 0.040 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 362 | 0.040 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.040 |
Why?
| | Transfection | 1 | 2019 | 866 | 0.040 |
Why?
| | Body Mass Index | 2 | 2015 | 1971 | 0.040 |
Why?
| | Family | 1 | 2021 | 594 | 0.040 |
Why?
| | Forensic Medicine | 1 | 2017 | 16 | 0.040 |
Why?
| | Gestational Age | 1 | 2020 | 758 | 0.040 |
Why?
| | Pyrrolidines | 1 | 2017 | 56 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2018 | 90 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2018 | 202 | 0.040 |
Why?
| | Escherichia coli | 1 | 2020 | 730 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 302 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 231 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 91 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 357 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 511 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 19 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1137 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 624 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 254 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 9130 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 287 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 6264 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2578 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 248 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 7 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 61 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 22 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1217 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 5 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 646 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 29 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 194 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 207 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 73 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2335 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1598 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 731 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 348 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 173 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 296 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 119 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6165 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2418 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 332 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 41 | 0.030 |
Why?
| | Cyclopropanes | 1 | 2013 | 81 | 0.030 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 87 | 0.030 |
Why?
| | Androstadienes | 1 | 2013 | 97 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 715 | 0.030 |
Why?
| | Albuterol | 1 | 2013 | 105 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4116 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1870 | 0.030 |
Why?
| | Acetates | 1 | 2013 | 96 | 0.030 |
Why?
| | Sulfides | 1 | 2013 | 94 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2013 | 294 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 431 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1485 | 0.030 |
Why?
| | Vasodilation | 1 | 2015 | 412 | 0.030 |
Why?
| | Quinolines | 1 | 2013 | 129 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 390 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 317 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2013 | 209 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 516 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 417 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 30 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 345 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 282 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 533 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 260 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 153 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 457 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 795 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 959 | 0.020 |
Why?
| | Salts | 1 | 2010 | 36 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 832 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 1853 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4438 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 75 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 65 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 50 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 509 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 3 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 21 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 726 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 141 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 55 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 644 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 3 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 7 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 198 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 25 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5059 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 271 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 47 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1138 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 91 | 0.020 |
Why?
| | Risk | 1 | 2011 | 819 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 33 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 109 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 167 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 347 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 88 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 157 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 385 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 178 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 115 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 822 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 238 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 546 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 794 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1490 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 2907 | 0.020 |
Why?
| | United States | 1 | 2022 | 12297 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 400 | 0.020 |
Why?
| | Cell Membrane | 1 | 2009 | 683 | 0.020 |
Why?
| | Histones | 1 | 2010 | 540 | 0.020 |
Why?
| | Pyrimidines | 1 | 2008 | 376 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1122 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2009 | 781 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2010 | 961 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1536 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2392 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 20 | 0.010 |
Why?
| | Germination | 1 | 2003 | 5 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 91 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1756 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1210 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1265 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 8699 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 4668 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|